Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic ER+ Breast Cancer
Interventions: DRUG: TTC-352
Sponsor: TTC Oncology, LLC